Proliferating Pilar Tumors: Can Immunohistochemistry Differentiate Benign and Malignant Forms?

BACKGROUND Proliferating pilar tumor (PPT) is an adnexal tumor of purported differentiation toward the follicular outer root sheath. Immunohistochemistry has been suggested to differentiate between benign and malignant forms. METHODS Eleven benign (PPT) and 9 malignant PPT lesions were reviewed; Ki67, p27, and p53 were applied. The staining intensity (strong, moderate, weak, and negative), positive cell numbers, and marker indexes (%) were scored using image-analysis software (ViraSoft). RESULTS Overall, there was no significant correlation between Ki67 and p53 and histopathological features. However, malignant PPTs had significantly lower numbers of p27-positive cells (P = 0.030). CONCLUSIONS Our study includes the largest group of patients in whom image analysis of p53, Ki67, and p27 has been used to try to separate benign from malignant lesions. Although there were no significant differences regarding Ki67 and p53, malignant lesions have a statistically lower expression of p27. Further studies may be needed to determine the clinical usefulness of image analysis in this differential diagnosis.

[1]  M. Keleş,et al.  A Rare Cutaneous Adnexal Tumor: Malignant Proliferating Trichilemmal Tumor , 2015, Case reports in medicine.

[2]  L. Pincus,et al.  Cutaneous Adnexal Tumors , 2012 .

[3]  Sandip Jadhav,et al.  Low-grade Malignant Proliferating Pilar Tumor Simulating a Squamous-Cell Carcinoma in an Elderly Female: A Case Report and Immunohistochemical Study , 2011, International journal of trichology.

[4]  A. C. Ferrasi,et al.  Gastric adenocarcinoma and Helicobacter pylori: correlation with p53 mutation and p27 immunoexpression. , 2010, Cancer epidemiology.

[5]  P. Garg,et al.  Malignant proliferating trichilemmal cyst: a case report with review of literature. , 2009, The Malaysian journal of pathology.

[6]  Jay J. Ye,et al.  Proliferating pilar tumors: a clinicopathologic study of 76 cases with a proposal for definition of benign and malignant variants. , 2004, American journal of clinical pathology.

[7]  A. Folpe,et al.  Proliferating trichilemmal tumors: clinicopathologic evaluation is a guide to biologic behavior , 2003, Journal of cutaneous pathology.

[8]  Maria Bai,et al.  Low Expression of p27 Protein Combined with Altered p53 and Rb/p16 Expression Status Is Associated with Increased Expression of Cyclin A and Cyclin B1 in Diffuse Large B-Cell Lymphomas , 2001, Modern Pathology.

[9]  A. Ariza,et al.  Proliferating trichilemmal tumour: p53 immunoreactivity in association with p27Kip1 over‐expression indicates a low‐grade carcinoma profile , 2001, Histopathology.

[10]  Fernandez Sh Malignant proliferating trichilemmal tumour: a case report. , 1999 .

[11]  D. Cotton Neoplasms with Follicular Differentiation , 1993 .

[12]  M. Wick,et al.  Cutaneous adnexal tumors : a guide to pathologic diagnosis , 1991 .

[13]  M. Born,et al.  Proliferating trichilemmal cyst , 1983, Journal of cutaneous pathology.

[14]  T. Saida,et al.  Development of a malignant proliferating trichilemmal cyst in a patient with multiple trichilemmal cysts. , 1983, Dermatologica.

[15]  M. H. Brownstein,et al.  Proliferating trichilemmal cyst: A simulant of squamous cell carcinoma , 1981, Cancer.

[16]  E. W. Jones Proliferating epidermoid cysts. , 1966, Archives of dermatology.